Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil effectively treats female pattern hair loss.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

A natural steroid in the body may protect against eye damage in glaucoma.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The normal human prostate does not significantly affect blood DHT levels.